Remove Gene Editing Remove Gene Sequencing Remove Life Science Remove Pharma Companies
article thumbnail

Touchlight boosts DNA manufacturing capacity with latest expansion

Pharmaceutical Technology

After raising $125m in 2021 to redevelop the facility, more recently Touchlight secured an additional $17.3m (£14m) from the UK government’s Life Sciences Innovative Manufacturing Fund to accelerate its expansion plans and scale-up equipment. Rapid production will potentially enable researchers to overcome an industry bottleneck.

DNA 130